Glucose Control During Labour and Delivery in Type 1 Diabetes - An Update on Current Evidence.

IF 5.2 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Current Diabetes Reports Pub Date : 2024-11-22 DOI:10.1007/s11892-024-01563-1

Lene Ringholm, Julie Carstens Søholm, Berit Woetmann Pedersen, Tine Dalsgaard Clausen, Peter Damm, Elisabeth Reinhardt Mathiesen

{"title":"Glucose Control During Labour and Delivery in Type 1 Diabetes - An Update on Current Evidence.","authors":"Lene Ringholm, Julie Carstens Søholm, Berit Woetmann Pedersen, Tine Dalsgaard Clausen, Peter Damm, Elisabeth Reinhardt Mathiesen","doi":"10.1007/s11892-024-01563-1","DOIUrl":null,"url":null,"abstract":"Purpose of review: To provide an update on diabetes management during labour and delivery in women with type 1 diabetes with focus on appropriate insulin administration, carbohydrate supply and use of diabetes technology to support safe delivery and neonatal well-being.Recent findings: During active labour and elective cesarean section capillary blood glucose monitoring or continuous glucose monitoring at least hourly is recommended. Infusion with isotonic (5%) glucose can be given with adjustable infusion rate to address maternal carbohydrate requirements and to prevent maternal hypoglycemia. Subcutaneous insulin administration with multiple injections or insulin pump therapy is considered at least as safe and efficient as intravenous administration to obtain tight glycemic targets. Automated insulin delivery via insulin pump can be continued during labour and delivery. Diabetes management during labour and delivery involves intensive glucose monitoring, adequate insulin administration and carbohydrate administration to support safe delivery and neonatal well-being.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"25 1","pages":"7"},"PeriodicalIF":5.2000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Diabetes Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11892-024-01563-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: To provide an update on diabetes management during labour and delivery in women with type 1 diabetes with focus on appropriate insulin administration, carbohydrate supply and use of diabetes technology to support safe delivery and neonatal well-being.

Recent findings: During active labour and elective cesarean section capillary blood glucose monitoring or continuous glucose monitoring at least hourly is recommended. Infusion with isotonic (5%) glucose can be given with adjustable infusion rate to address maternal carbohydrate requirements and to prevent maternal hypoglycemia. Subcutaneous insulin administration with multiple injections or insulin pump therapy is considered at least as safe and efficient as intravenous administration to obtain tight glycemic targets. Automated insulin delivery via insulin pump can be continued during labour and delivery. Diabetes management during labour and delivery involves intensive glucose monitoring, adequate insulin administration and carbohydrate administration to support safe delivery and neonatal well-being.

查看原文本刊更多论文

1 型糖尿病患者分娩期间的血糖控制 - 最新证据。

综述目的：提供有关 1 型糖尿病产妇在分娩过程中糖尿病管理的最新信息，重点关注胰岛素的适当管理、碳水化合物的供应以及糖尿病技术的使用，以支持安全分娩和新生儿的健康：建议在活跃产程和择期剖宫产过程中至少每小时进行一次毛细血管血糖监测或连续血糖监测。可输注等渗（5%）葡萄糖，输注速度可调，以满足产妇对碳水化合物的需求，并防止产妇低血糖。多次皮下注射胰岛素或胰岛素泵治疗至少与静脉注射胰岛素同样安全有效，可实现严格的血糖目标。通过胰岛素泵自动输送胰岛素可在分娩过程中继续进行。分娩和生产期间的糖尿病管理包括强化血糖监测、充足的胰岛素给药和碳水化合物给药，以支持安全分娩和新生儿的健康。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Diabetes Reports 医学 -

CiteScore

9.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of diabetes epidemiology, pathophysiology, and management. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.